09/23/2026
"It's the 'and' thing. It's NAMS and nonhuman primates." That's Dr. R. Paul Johnson, director of Emory's National Biomedical Research Center, on a new episode of PRIM&R's Research Ethics Reimagined. He and Dr. Joyce Cohen, the center's veterinarian, spent nearly 50 minutes making a case we've been making too: New Approach Methods and nonhuman primate research aren't rivals, they're partners.
A few things worth pulling out. About 70% of Emory's researchers now use NAMs alongside nonhuman primate models, not instead of them. Their belatacept story is a great case study in why: a promising transplant drug that worked in mice, failed in monkeys, got refined, then succeeded, and is now standard care for kidney transplant patients at Emory. Skip the monkey studies, and that failure happens in a human trial instead.
Dr. Cohen also put it plainly: "I wish they understood how much the people here working with the animals care about what we do and how much compassion there is." Their IACUC (the required oversight committee) has over 50 members, and the center holds public open houses twice a year so people can see that for themselves.
Worth the full listen: share.transistor.fm/s/8fdae056